Showing 50 of 457 results for term: 2025年4月18日 中国银行 历史行情
  • Strategic review of Performance Technologies and Industrial Chemicals businesses

    The core objective will be to establish what ownership structure best serves this part of Croda’s business going forward, to create a stronger platform for its future growth.

  • Strong strategic delivery built on resilient financial performance

    Croda 2020 full-year results, strong strategic delivery built on resilient financial performance

  • Appointment of Non-Executive Director, Jill Anderson

    9 January2026: We are pleased to announce the appointment of Jill Anderson as Non-Executive Director.

  • Sentient Science and Croda partner for wind asset life extension

    Croda announce a new partnership with Sentient Science for the recommended use of Croda’s Rewitec additives

  • Construction underway on our new North American Headquarters and innovation centre

    The sustainable facility will bring together commercial and technical teams from across our business areas

  • Supporting local school children during lockdown

    We are supporting school children in the UK by gifting our pre-owned laptops and tablets to pupils having lessons at home

  • Croda urges G20 leaders to keep Paris Agreement within reach

    Croda is signatory to an open letter to all G20 leaders, urging them to keep the Paris Agreement’s 1.5°C goal within reach.

  • Signatory to the if not now then when campaign

    We have joined over 70 major UK businesses in becoming a signatory to the Black inclusion business campaign.

  • Latin America

    In Latin America, we have a manufacturing site in Campinas, Brazil and six other sales offices within the region.

  • Where we operate

    Every day our global team, across 37 countries, work together to inspire our customers.

  • Focusing on D&I in Asia

    Colleagues in Asia have been leading a programme of raising awareness, building an inclusive culture, and driving inclusivity in recruitment.

  • Investing in mRNA and gene therapy

    As the core of our lipid systems capability within the Health Care business, Avanti is primarily focused on developing innovative lipid-based products of unparalleled purity to address specific medical challenges that are not resolved by current technology.

  • ASD Kaleka Mosaik Initiative Impact Fund

    We are contributing to the first Impact Fund of ASD, developed in partnership with Tides Foundation.

  • Sustainable ways of working in R&D

    We are focused on aligning the work of our global R&D teams with the United Nations Sustainable Development Goals (SDGs).

  • Externally validated avoided emissions

    The emissions savings of this new product were revealed during its sustainability assessment, part of the new way of working for our innovation teams to support our Commitment.

  • Supporting Invisible Disabilities Week at Croda

    Learn how Croda supports Invisible Disabilities Week, promoting awareness and inclusivity for employees with hidden disabilities. Discover personal stories, like Sana Bell’s, and our commitment to creating a supportive workplace for everyone to thrive.

  • Navigating the future of innovative ingredients

    As Croda celebrates 100 years of delivering Smart science to improve lives™, we’re also looking ahead. This Vision Report is a forward-looking guide to the trends that will reshape the speciality ingredients industry across the next quarter-century.

  • 100 years of smart science: Celebrating Croda's centenary across the globe

    Join us as we celebrate Croda’s 100-year journey from a small family firm in Yorkshire to a global leader in sustainable innovation. Discover the science, stories, and people behind a century of improving lives.

  • Making every minute count

    Take a look at how employees across the Croda Group have spent their 1% Club time helping their communities.

  • International Day of Women and Girls in Science

    At Croda, we recognise that by championing gender equality in STEM, we can adopt a future where talent determines success; while promoting inclusivity, and empowering the next generation of female scientists, engineers, and innovators.

  • Life at Croda

    Celebrate the amazing people who make Croda International unique. Dive into inspiring stories, innovative projects, and the value of Together that drives our mission Smart science to improve lives™.

  • Media hub

    Explore the latest news, blogs, and media from Croda on our innovative ingredients, sustainability achievements, and global collaborations.

  • Launching futures

    Embarking on excellence with our transformative graduate scheme

  • Supporting Mental Health at Croda

    Employers can do more to create a happy, healthy workforce by putting mental health at the forefront; hear how we are supporting mental health at Croda.

  • Contact media enquiries

    For enquiries, contact media.enquiries@croda.com

  • Diversity and inclusion

    In 2021 we defined a D&I roadmap identifying actions, regarding diversity and inclusion, in five key areas.

  • Customer driven

    We are listening more closely to our customers than ever before; understanding the things that are of most importance to our customers and how we are performing against them.

  • Advancing the efficacy and impact of vaccines

    The acquisition of Biosector in 2018 strengthened our pharmaceutical offering, taking us into the field of vaccine adjuvants.

  • Acts of kindness

    The Croda Acts of Kindness programme gave employees the opportunity to nominate local causes and charities to support during COVID-19, with each major site given £10,000.

  • Abiotic stress mitigation in onions

    Changing climates mean higher temperatures, periods of drought and higher salinity are becoming an increasing problem for farmers.

  • Flue2Chem

    In another example of industry-wide collaboration to help tackle the climate emergency, the Flue2Chem Innovate UK project aims to demonstrate that a UK supply chain to produce alkoxylated surfacants from CO2 is economically and technically feasible.

  • Digitalisation in manufacturing

    We can see the potential of big data, robotics, analytics and the Internet of Things to drive manufacturing excellence and contribute to our right first time agenda.

  • Net zero roadmap for UK manufacturing site

    We became one of the first UK manufacturing sites to develop a 2050 net zero roadmap as part of the UK Government’s Department for Business, Energy and Industrial Strategy ‘Industry of the Future’ programme.

  • Advocating for Access and Benefit Sharing and biodiversity conservation

    We supported the launch of the third edition of the Brogota Project through the United Nations Biodiversity Conference COP15 side event.

  • Improving performance by humanising safety

    Involvement and engagement have increased, and longstanding infrastructure and operational issues are being addressed following a pilot Human Performance Programme at our site in Thane, India.

  • Transition to bio-based MPG

    Transitioning our raw materials to bio-based sources will enable us to make a significant positive impact.

  • Life cycle assesment

    Supporting our customers to realise the benefits of LCA meant that in 2022 we began developing our LCA Centre of Excellence, supporting sectors in examining the risks and benefits of their portfolios.

  • Uni of Cambridge case study

    Working with technology designers NiTech Solutions and The University of Cambridge’s Institute for Manufacturing, we created a new process to manufacture more sustainable surfactants. Traditionally, industrial production of surfactants often occurs in large batch reactors, which have low energy efficiency and a long reaction time.

  • Leveraging expertise in UV filters for Asian markets

    There are over three million cases of skin cancer globally each year, responsible for tens of thousands of deaths. Our range of sunscreens meets a clear need and is an important pillar of our sustainability Commitment to be People Positive by 2030.

  • Human Performance programme

    Our behavioural safety improvement programmes were standardised into a Group-wide Behavioural Safety Observation programme, implemented across all manufacturing sites since 2015.

  • Reforestation

    Revitalising ecosystems, improving biodiversity and creating social and economic benefits for local communities.

  • 1.5°C science-based target validation

    In July 2021 we became only the third major chemical company globally to have a 1.5ºC science-based target validated.

  • Croda Foundation

    We have taken a big step towards achieving our ambition of expanding the reach of our smart science to permanently improve more lives by funding the Croda Foundation.

  • Collaboration to deliver new vaccine adjuvants

    In 2021 we established a strategic collaboration with the Danish government’s life science research institute, Statens Serum Institute (SSI).

  • Responsible business

    /Images/Corporate/Corporate V2/Sustainability/Our commitment sustainability image

  • Coltide Radiance sustainability in use

    In October we were delighted that our sustainability leadership was recognised as we won Business of the Year at the World Sustainability Awards.

  • Waste management

    Iberchem, our global fragrance and flavours business based in Spain, has championed waste management best practices through robust policies and employee education programmes.

  • Agroforestry in the Amazon

    The Croda Foundation is supporting an Instituto Amazonas agroforestry project, which aims to revive traditional agriculture practices among indigenous tribes, improving food security and protecting their cultural heritage and environment.

  • Improving the customer experience in China

    Our .CN website transformation, which was launched in 2020, has created an entirely new online experience for customers in fast-growing Chinese markets.

  • Supplying delivery systems to help prevent cardiovascular disease

    Nucleic acid-based therapies are the next big blockbuster drug class opening up exciting applications such as gene editing, where a patient’s genetic material can be modified to correct a disorder.